Position in MYGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,305,071
+$1,175,854 QoQ
Shares Held
228,559
+696.0% QoQ
Ownership
0.239%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#48
of 197 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Jain Global LLC holds $52,586,277 across 12 Diagnostics & Research names. MYGN ranks #7 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
81,417 | $12,214,992 | |
| 2 | WAT |
Waters Corp /De/
|
25,839 | $9,690,658 | |
| 3 | NTRA |
Natera, Inc.
|
34,912 | $9,476,862 | |
| 4 | A |
Agilent Technologies, Inc.
|
43,794 | $5,817,157 | |
| 5 | QGEN |
Qiagen N.V.
|
148,504 | $5,806,506 | |
| 6 | SHC |
Sotera Health Co
|
321,452 | $5,705,773 | |
| 7 | MYGN |
Myriad Genetics Inc
This page
|
228,559 | $1,305,071 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
1,561 | $826,689 |
All Filings in MYGN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,305,071 | 228,559 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $129,217 | 28,715 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,162,091 | 188,958 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $560,137 | 77,474 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $494,647 | 93,154 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $258,640 | 29,159 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||